SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001477932-24-002842
Filing Date
2024-05-14
Accepted
2024-05-14 16:00:26
Documents
7
Period of Report
2024-05-24

Document Format Files

Seq Description Document Type Size
1 FORM 6-K betrf_6k.htm 6-K 10834
2 NOTICE OF ANNUAL GENERAL MEETING AND INFORMATION betrf_ex991.htm EX-99.1 202945
3 FORM OF PROXY betrf_ex992.htm EX-99.2 59934
4 NOTICE AND ACCESS betrf_ex993.htm EX-99.3 19625
5 betrf_ex992img1.jpg GRAPHIC 3539
6 betrf_ex992img2.jpg GRAPHIC 3539
7 betrf_ex992img3.jpg GRAPHIC 3539
  Complete submission text file 0001477932-24-002842.txt   309587
Mailing Address 1275 WEST 6TH AVENUE VANCOUVER A1 V6H 1A6
Business Address 1275 WEST 6TH AVENUE VANCOUVER A1 V6H 1A6 438-884-8841
BetterLife Pharma Inc. (Filer) CIK: 0001464165 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0131
Type: 6-K | Act: 34 | File No.: 333-161157 | Film No.: 24944029
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)